Non-Small Cell Lung Cancer Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Non-Small Cell Lung Cancer Treatment (NSCLC) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Overall Market Size
2.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size: 2024 VS 2032
2.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-Small Cell Lung Cancer Treatment (NSCLC) Players in Global Market
3.2 Top Global Non-Small Cell Lung Cancer Treatment (NSCLC) Companies Ranked by Revenue
3.3 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue by Companies
3.4 Top 3 and Top 5 Non-Small Cell Lung Cancer Treatment (NSCLC) Companies in Global Market, by Revenue in 2024
3.5 Global Companies Non-Small Cell Lung Cancer Treatment (NSCLC) Product Type
3.6 Tier 1, Tier 2, and Tier 3 Non-Small Cell Lung Cancer Treatment (NSCLC) Players in Global Market
3.6.1 List of Global Tier 1 Non-Small Cell Lung Cancer Treatment (NSCLC) Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Small Cell Lung Cancer Treatment (NSCLC) Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Markets, 2024 & 2032
4.1.2 Angiogenesis Inhibitor
4.1.3 Epidermal Growth Factor Receptor Blocker
4.1.4 Kinase Inhibitor
4.1.5 Microtubule Stabilizer
4.1.6 Folate Antimetabolites
4.1.7 Others
4.2 Segmentation by Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue & Forecasts
4.2.1 Segmentation by Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2024 & 2032
5.1.2 Adenocarcinoma
5.1.3 Squamous Cell Carcinoma
5.1.4 Large Cell Carcinoma
5.2 Segmentation by Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue & Forecasts
5.2.1 Segmentation by Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2024 & 2032
6.2 By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue & Forecasts
6.2.1 By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2020-2025
6.2.2 By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2026-2032
6.2.3 By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2020-2032
6.3.2 United States Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.3.3 Canada Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.3.4 Mexico Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2020-2032
6.4.2 Germany Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.4.3 France Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.4.4 U.K. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.4.5 Italy Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.4.6 Russia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.4.7 Nordic Countries Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.4.8 Benelux Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2020-2032
6.5.2 China Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.5.3 Japan Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.5.4 South Korea Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.5.5 Southeast Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.5.6 India Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2020-2032
6.6.2 Brazil Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.6.3 Argentina Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2020-2032
6.7.2 Turkey Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.7.3 Israel Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.7.4 Saudi Arabia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
6.7.5 UAE Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2020-2032
7 Companies Profiles
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Corporate Summary
7.1.2 AbbVie Inc. Business Overview
7.1.3 AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.1.4 AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2020-2025)
7.1.5 AbbVie Inc. Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Corporate Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.2.4 Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2020-2025)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.3.4 AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2020-2025)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Avid Bioservices Inc.
7.4.1 Avid Bioservices Inc. Corporate Summary
7.4.2 Avid Bioservices Inc. Business Overview
7.4.3 Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.4.4 Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2020-2025)
7.4.5 Avid Bioservices Inc. Key News & Latest Developments
7.5 Bayer Healthcare
7.5.1 Bayer Healthcare Corporate Summary
7.5.2 Bayer Healthcare Business Overview
7.5.3 Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.5.4 Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2020-2025)
7.5.5 Bayer Healthcare Key News & Latest Developments
7.6 Biogen Inc.
7.6.1 Biogen Inc. Corporate Summary
7.6.2 Biogen Inc. Business Overview
7.6.3 Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.6.4 Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2020-2025)
7.6.5 Biogen Inc. Key News & Latest Developments
7.7 Blueprint Medicines Corp
7.7.1 Blueprint Medicines Corp Corporate Summary
7.7.2 Blueprint Medicines Corp Business Overview
7.7.3 Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.7.4 Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2020-2025)
7.7.5 Blueprint Medicines Corp Key News & Latest Developments
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Corporate Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.8.4 Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2020-2025)
7.8.5 Eli Lilly and Company Key News & Latest Developments
7.9 Merck & co Inc.
7.9.1 Merck & co Inc. Corporate Summary
7.9.2 Merck & co Inc. Business Overview
7.9.3 Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.9.4 Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2020-2025)
7.9.5 Merck & co Inc. Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.10.4 Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2020-2025)
7.10.5 Novartis Key News & Latest Developments
7.11 Pfizer Inc.
7.11.1 Pfizer Inc. Corporate Summary
7.11.2 Pfizer Inc. Business Overview
7.11.3 Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.11.4 Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2020-2025)
7.11.5 Pfizer Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Opportunities & Trends in Global Market
Table 2. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Drivers in Global Market
Table 3. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Restraints in Global Market
Table 4. Key Players of Non-Small Cell Lung Cancer Treatment (NSCLC) in Global Market
Table 5. Top Non-Small Cell Lung Cancer Treatment (NSCLC) Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Share by Companies, 2020-2025
Table 8. Global Companies Non-Small Cell Lung Cancer Treatment (NSCLC) Product Type
Table 9. List of Global Tier 1 Non-Small Cell Lung Cancer Treatment (NSCLC) Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Small Cell Lung Cancer Treatment (NSCLC) Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2026-2032
Table 30. AbbVie Inc. Corporate Summary
Table 31. AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Offerings
Table 32. AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn) & (2020-2025)
Table 33. AbbVie Inc. Key News & Latest Developments
Table 34. Astellas Pharma Corporate Summary
Table 35. Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Product Offerings
Table 36. Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn) & (2020-2025)
Table 37. Astellas Pharma Key News & Latest Developments
Table 38. AstraZeneca Corporate Summary
Table 39. AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Product Offerings
Table 40. AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn) & (2020-2025)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Avid Bioservices Inc. Corporate Summary
Table 43. Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Offerings
Table 44. Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn) & (2020-2025)
Table 45. Avid Bioservices Inc. Key News & Latest Developments
Table 46. Bayer Healthcare Corporate Summary
Table 47. Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Product Offerings
Table 48. Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn) & (2020-2025)
Table 49. Bayer Healthcare Key News & Latest Developments
Table 50. Biogen Inc. Corporate Summary
Table 51. Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Offerings
Table 52. Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn) & (2020-2025)
Table 53. Biogen Inc. Key News & Latest Developments
Table 54. Blueprint Medicines Corp Corporate Summary
Table 55. Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Product Offerings
Table 56. Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn) & (2020-2025)
Table 57. Blueprint Medicines Corp Key News & Latest Developments
Table 58. Eli Lilly and Company Corporate Summary
Table 59. Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Product Offerings
Table 60. Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn) & (2020-2025)
Table 61. Eli Lilly and Company Key News & Latest Developments
Table 62. Merck & co Inc. Corporate Summary
Table 63. Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Offerings
Table 64. Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn) & (2020-2025)
Table 65. Merck & co Inc. Key News & Latest Developments
Table 66. Novartis Corporate Summary
Table 67. Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Product Offerings
Table 68. Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn) & (2020-2025)
Table 69. Novartis Key News & Latest Developments
Table 70. Pfizer Inc. Corporate Summary
Table 71. Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Offerings
Table 72. Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (US$, Mn) & (2020-2025)
Table 73. Pfizer Inc. Key News & Latest Developments
List of Figures
Figure 1. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Picture
Figure 2. Non-Small Cell Lung Cancer Treatment (NSCLC) Segment by Type in 2024
Figure 3. Non-Small Cell Lung Cancer Treatment (NSCLC) Segment by Application in 2024
Figure 4. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in 2024
Figure 9. Segmentation by Type � Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2020-2032
Figure 13. By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2020-2032
Figure 14. By Country - North America Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2020-2032
Figure 15. United States Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2020-2032
Figure 19. Germany Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 20. France Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2020-2032
Figure 27. China Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 31. India Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2020-2032
Figure 33. Brazil Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2020-2032
Figure 36. Turkey Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, (US$, Mn), 2020-2032
Figure 40. AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Industry Market Size
